Also trades as: HLS.TO (TSX) · $vol 0M
HLTRF OTC
HLS Therapeutics Inc.
1W: -1.4%
1M: +4.2%
3M: -8.3%
YTD: -19.8%
1Y: -27.6%
3Y: -37.8%
5Y: -80.8%
$2.75
-0.04 (-1.43%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Balance Sheet Trends
Total Assets
$137M
-14.1% ▼
5Y CAGR: -14.7%
Total Liabilities
$76M
-14.5% ▼
5Y CAGR: -10.9%
Shareholders Equity
$62M
-13.7% ▼
5Y CAGR: -18.3%
Cash & Investments
$12M
-33.0% ▼
5Y CAGR: -10.7%
Total Debt
$50M
-25.2% ▼
5Y CAGR: -14.2%
Net Debt
$38M
-22.4% ▼
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $21M | $21M | $22M | $17M | $12M |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 |
| Cash & ST Investments | $21M | $21M | $22M | $17M | $12M |
| Net Receivables | $12M | $11M | $11M | $8M | $8M |
| Inventory | $9M | $9M | $10M | $9M | $8M |
| Other Current Assets | $2M | $4M | $2K | $0 | $1M |
| Total Current Assets | $44M | $44M | $44M | $35M | $29M |
| Property, Plant & Equip. | $2M | $1M | $965K | $997K | $1M |
| Goodwill & Intangibles | $229M | $195M | $162M | $122M | $105M |
| Long-Term Investments | $713K | $668K | $5K | $0 | $0 |
| Other Non-Current Assets | $967 | $303 | $619K | $528K | $327K |
| Total Non-Current Assets | $232M | $197M | $165M | $125M | $108M |
| Total Assets | $276M | $242M | $209M | $160M | $137M |
| — Liabilities — | |||||
| Accounts Payable | $9M | $12M | $14M | $9M | $10M |
| Short-Term Debt | $12M | $13M | $5M | $5M | $5M |
| Deferred Revenue | $5M | $4M | $0 | $0 | $0 |
| Other Current Liabilities | $901K | $2M | $7M | $8M | $10M |
| Total Current Liabilities | $28M | $31M | $27M | $23M | $26M |
| Long-Term Debt | $84M | $83M | $82M | $61M | $44M |
| Other Non-Current Liab. | $3M | $1M | $2M | $778K | $2M |
| Total Non-Current Liabilities | $87M | $85M | $85M | $66M | $50M |
| Total Liabilities | $115M | $116M | $111M | $89M | $76M |
| — Equity — | |||||
| Common Stock | $266M | $265M | $262M | $261M | $256M |
| Retained Earnings | -$120M | -$148M | -$175M | -$194M | -$204M |
| Accumulated OCI | $3M | -$5M | -$3M | -$10M | -$7M |
| Total Stockholders Equity | $161M | $125M | $98M | $71M | $62M |
| Total Liabilities & Equity | $276M | $242M | $209M | $160M | $137M |
| — Key Metrics — | |||||
| Total Debt | $98M | $97M | $88M | $66M | $50M |
| Net Debt | $76M | $77M | $66M | $49M | $38M |
| Total Investments | $713K | $668K | $5K | $0 | $0 |